BioLASCO Taiwan Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was TWD 59.75 million compared to TWD 59.81 million a year ago. Net income was TWD 11.81 million compared to TWD 14.07 million a year ago. Basic earnings per share from continuing operations was TWD 0.46 compared to TWD 0.55 a year ago. Diluted earnings per share from continuing operations was TWD 0.46 compared to TWD 0.55 a year ago.
For the nine months, sales was TWD 166.56 million compared to TWD 169.01 million a year ago. Net income was TWD 29.76 million compared to TWD 31.8 million a year ago. Basic earnings per share from continuing operations was TWD 1.16 compared to TWD 1.24 a year ago. Diluted earnings per share from continuing operations was TWD 1.16 compared to TWD 1.24 a year ago.